SCHEMBL4904959

SCHEMBL4904959

CCN(c1csc(-c2ccc(F)cc2F)n1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
ALDH1A1 P00352 2/20 0.35
TSHR P16473 2/20 0.35
ALPL P05186 1/20 0.35
KDM4E B2RXH2 2/20 0.35
KCNH2 Q12809 1/20 0.34
LMNA P02545 5/20 0.34
HPGD P15428 1/20 0.34
TP53 P04637 3/20 0.33
ATM Q13315 1/20 0.32
MAPK1 P28482 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909123 0.90 MAPT (0.39) MAPTNPC1RAB9APSEN1PSEN2
SCHEMBL4906663 0.90 LMNA (0.41) MAPTNPC1RAB9AALDH1A1TSHR
SCHEMBL4902485 0.89 TP53 (0.40) MAPTNPC1RAB9APSEN1PSEN2
SCHEMBL4911850 0.87 ALDH1A1 (0.39) MAPTNPC1RAB9APSEN1PSEN2
SCHEMBL4898066 0.84 ALDH1A1 (0.39) MAPTALDH1A1TSHRLMNATP53
SCHEMBL4907283 0.84 TP53 (0.42) MAPTNPC1RAB9AALDH1A1TSHR
SCHEMBL4906525 0.82 LMNA (0.47) MAPTNPC1RAB9AALDH1A1TSHR
SCHEMBL4900904 0.81 NR1I2 (0.36) MAPTNPC1RAB9AALDH1A1TSHR
SCHEMBL4902584 0.79 MAPT (0.43) MAPTNPC1RAB9APSEN1PSEN2
SCHEMBL4904978 0.79 LMNA (0.41) MAPTALDH1A1TSHRLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MAPT 1858/4885NPC1 50/4885RAB9A 2581/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MAPT 1786/4885NPC1 59/4885RAB9A 2271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.